This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bachmann CJ, Manthey T et al (2013) Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany. Res Dev Disabil 34(9):2551–2563
Bachmann CJ, Lempp T et al (2014) Use of antipsychotic medication in German children and adolescents, 2005–2012. Dtsch Arztebl Int 111(3):25–34
Grinker RR, Yeargin-Allsopp M, Boyle C (2011) Culture and autism spectrum disorders: the impact on prevalence and recognition. In: Amaral D, Dawson G, Geschwind D (eds) Autism spectrum disorders. Oxford University Press, Oxford, pp 112–136
Hoffmann F, Bachmann C (2014) Auch bei Kindern und Jugendlichen gibt es Unterschiede in Soziodemographie, Gesundheit und Inanspruchnahme zwischen den Krankenkassenarten [Differences in sociodemographic characteristics, health, and health service use of children and adolescents according to their health insurance funds]. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 57(4):455–463
Hsia Y, Wong AY, Murphy DG, Simonoff E, Buitelaar JK, Wong IC (2014) Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology (Berlin) 231(6):999–1009
Murray ML, Hsia Y et al (2014) Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology (Berlin) 231(6):1011–1021
Rijcken CA, Boelema GJ et al (2003) Off-label use of antipsychotics in the community pharmacy: the sex differences. Pharmacopsychiatry 36(5):187–191
Rubin D (2013) Conflicting data on psychotropic use by children: two pieces to the same puzzle. JAMA Pediatr 167(2):189–190
Wong IC, Murray ML et al (2004) Increased prescribing trends of paediatric psychotropic medications. Arch Dis Child 89(12):1131–1132
Zoëga H, Baldursson G et al (2009) Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol 19(6):757–764
Conflict of interest
Dr Bachmann has received lecture fees from Actelion, Novartis, and Ferring as well as payment from BARMER GEK for writing a chapter in a book. He has served as a study physician in clinical trials for Shire and Novartis. Dr Hoffmann is active on behalf of a number of statutory health-insurance companies (BARMER GEK, DAK, TK and various corporate health-insurance funds) in the setting of contracts for third-party payment.
Comment on: Hsia Y, Wong AY, Murphy DG, Simonoff E, Buitelaar JK, Wong IC (2014) Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study. Psychopharmacology (Berl), 231(6): 999–1009.
About this article
Cite this article
Bachmann, C.J., Hoffmann, F. Determination of psychotropic use in children and adolescents from a prescription database: methodological issues. Psychopharmacology 231, 3809–3811 (2014). https://doi.org/10.1007/s00213-014-3691-2
- Autism Spectrum Disorder
- Autism Spectrum Disorder
- Rett Syndrome